A 2-Year Follow-up of Social Phobia: Status After a Brief Medication Trial
The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
Although social phobia is thought to be a chronic disorder, little is known about its long-term course in patients who engage in brief treatment studies. We, therefore, conducted a follow-up study of social phobics who had participated in a brief, placebo-controlled treatment trial of clonazepam. Of the original 75 subjects, 56 were assessed through telephone interview and self-report questionnaires that evaluated current social phobia symptoms. Information was also gathered about treatment received in the 2-year interval since the initial pharmacotherapy trial. The group as a whole showed maintenance of the gains acquired during initial treatment. On a number of symptom scales, subjects initially treated with clonazepam exhibited significantly less severe scores compared with placebo subjects. This study provides evidence of long-term benefit for social phobics when treated with a brief medication trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, additional studies all show a continuing anxiolytic effect, at least for panic disorder [69–72], generalized anxiety disorder [73], and social phobia [74–76].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [74]
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
Measurement of social-evaluative anxiety.
Watson, D., & Friend, R. (1969) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0027806 · Cited by 3,467
Brief standard self-rating for phobic patients
Marks, I. M., & Mathews, A. M. (1979) · Behaviour Research and Therapy · doi:10.1016/0005-7967(79)90041-x · Cited by 1,801
Schneier (1992) · doi:10.1001/archpsyc.1992.01820040034004 · Cited by 1,142
Post-traumatic stress disorder in the community: an epidemiological study
Davidson, J. R. T., Hughes, D., Blazer, D. G., & George, L. K. (1991) · Psychological Medicine · doi:10.1017/s0033291700022352 · Cited by 969
Self-citationFunctional impairment in social phobia.
Schneier, F. R., Heckelman, L., Garfinkel, R. S., Campeas, R. B., Fallon, B. A., Gitow, A., Street, L. L., Bene, D. D., & Liebowitz, M. R. (1994) · PubMed · Cited by 620
Treatments of Depression and the Functional Capacity to Work
Mintz, J. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100005001 · Cited by 563
Cognitive behavioral group treatment for social phobia: Comparison with a credible placebo control
Heimberg, R. G., Dodge, C. S., Hope, D. A., Kennedy, C. R., Zollo, L. J., & Becker, R. E. (1990) · Cognitive Therapy and Research · doi:10.1007/bf01173521 · Cited by 500
Quality of Life in Panic Disorder
Markowitz, J. S. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110026004 · Cited by 468
Phenelzine vs Atenolol in Social Phobia: A Placebo-Controlled Comparison
Liebowitz, M. R., Schneier, F., Campeas, R., Hollander, E., Hatterer, J., Fyer, A., Gorman, J., Papp, L., Davies, S., Gully, R., et al. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.49.4.290 · Cited by 444
Research works printed but not linked: 4
- Davidson, 1991, J Clin Psychiatry, 52, 48
- Davidson, 1994, J Clin Psychiatry, 55, 28
- Liebowitz, 1988, J Clin Psychiatry, 49, 252
- Schneier, 1994, J Clin Psychiatry, 55, 322
Cited by
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
Otto, M. W., Pollack, M. H., Gould, R. A., Worthington, J. J., McArdle, E. T., Rosenbaum, J. F., & Heimberg, R. G. (2000) · Journal of Anxiety Disorders · doi:10.1016/s0887-6185(00)00027-x · Cited by 175
The lifelong course of social anxiety disorder: a clinical perspective
Keller, M. B. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s417.6.x · Cited by 165
Current treatments of the anxiety disorders in adults
Ballenger, J. C. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00220-6 · Cited by 149
Pharmacotherapy for social anxiety disorder (SAnD)
Williams, T., Hattingh, C. J., Kariuki, C. M., Tromp, S. A., van Balkom, A. J., Ipser, J. C., & Stein, D. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001206.pub3 · Cited by 84
Metadata
- Authors
- SUTHERLAND, S. M., TUPLER, L. A., COLKET, J. T., & DAVIDSON, J. R. T.
- Affiliations
- Duke Medical Center (US)
- Venue
- The Journal of Nervous and Mental Disease
- Published
- 1996-12
- Volume
- 184
- Issue
- 12
- Pages
- 731-738
- ISSN
- 0022-3018 (ISSN-L)
- OpenAlex
- W2320957124
- Cited by
- 35
- References
- 23
- Citations by year
- 2026: 1 · 2024: 1 · 2017: 1 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Nervous and Mental Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- social anxiety disorder, clonazepam, long-term follow-up, maintenance of treatment gains, benzodiazepines
- MeSH terms
- Adult, Clonazepam, Double-Blind Method, Female, Follow-Up Studies, Health Status, Humans, Male, Phobic Disorders, Placebos, Probability, Psychiatric Status Rating Scales, Psychotherapy, Severity of Illness Index, Comorbidity, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A 2-Year Follow-up of Social Phobia: Status After a Brief Medication Trial. https://app.cochat.ai/papers/10.1097/00005053-199612000-00003
- The paper
- SUTHERLAND, S. M., TUPLER, L. A., COLKET, J. T., & DAVIDSON, J. R. T. (1996). A 2-Year Follow-up of Social Phobia: Status After a Brief Medication Trial. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/00005053-199612000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.